PROF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Profound Medical Corp (PROF) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows strong technical indicators, positive financial growth in revenue, and a recent analyst upgrade with a higher price target. Despite some concerns about net income and EPS, the company's gross margin improvement and resolved capital concerns make it a viable long-term investment.
The stock is showing bullish technical indicators. The MACD is positive and expanding, RSI is overbought at 82.755, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading above key resistance levels (R1: 7.633, R2: 8.063), indicating strong upward momentum.
Analyst upgrade with a price target increase to $
Strong revenue growth in Q3 2025 (up 86.76% YoY).
Gross margin improvement to 74.32% (up 17.71% YoY).
Resolved capital concerns with recent funding of $36M via direct offering and $6.45M in private placement.
Net income and EPS dropped to 0 in Q3 2025, reflecting profitability concerns.
RSI indicates overbought conditions, which may lead to short-term pullbacks.
In Q3 2025, revenue increased by 86.76% YoY to $5,289,000, and gross margin improved to 74.32% (up 17.71% YoY). However, net income and EPS dropped to 0, reflecting a lack of profitability.
Lake Street raised the price target to $12 from $11 and maintained a Buy rating, citing resolved capital concerns and a focus on the company's fundamental performance.
